Project BioShield Status
Department of Homeland Security Appropriations Act, 2004 passed 10/1/03 includes Bioshield appropriation
- Up to $890 MM in ’04
- Up to $3.4 B ’04 – ’08
- Up to $5.6 B ’04 – ‘13
BioShield procurement of vaccines through HHS
Office of the Assistant Secretary for Public Health Emergency Preparedness
BioShield approved by the House, Senate action pending
CBO report (5/7/03) provides budget estimates for procurement of smallpox, anthrax, botulinum toxin, ebola, plague vaccines
Request for Information RFI-ORDC-03-01 issued 8/03
- Large scale manufacture of rPA anthrax vaccine and attenuated smallpox vaccine, emergency stockpile